chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12 hours after injection fever, chills, and fatigue. I had an episode of my body  wanting to fall to right as walking. I slept rest of day.  Day 2 still tired but forced my self to be active and complete some tasks. On third day felt better and did several chores throughout the day. At 5 pm I had a sudden surge of my body to pull right then immediate spin of room. I went to the floor as I knew I would faint.  I did not lose consciousness but had to be transported by ambulance to hospital to stabilize. Vomited 12-15 times. Was administered Zofran, Compazine, Ativan in the ER to help with spinning in my head. My thought is that this vaccine triggered my . Meniere disease. This vaccine maybe should have a warning  for Meniere' patients about this so no one else has to go through what I did.  Today is day five and my spinning is gone but am very wiped out from the experience.
Information has been received from a consumer concerning her daughter, an approximately 12 month old female who in 2008 was vaccinated with ATTENUVAX. The consumer reported that her daughter received ATTENUVAX in 2008 and developed a rash in 2008. The patient was brought to physician. At the time of report, the patient's outcome was unknown. The patient also developed the chicken pox while received chicken pox vaccine (1108USA00001). No further information is available.
Pt was given the vaccine in her left arm.  pt went unresponsive and began to have seizure like activity .  Pt was in a chair and lowered to the floor with the assistance of the nurse on her right side. 911 was called. 02 at 2L was administered. pt then became responsive. EMTs arrived and transported pt to hospital.
patient was administered two doses of GARDASIL before 2014. Caller reports that the patient is unsure if they received a third dose of GARDASIL 9; This spontaneous report was received from a medical assistant referring to currently 30-year-old patient. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided.     Before 2014, on unspecified dates, the patient was vaccinated with the first and second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) for prophylaxis (strength, dose, route of administration, anatomical location, lot # and expiration date were not reported).   At reporting time, the patient was unsure if they received a third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, route of administration, anatomical location, lot # and expiration date were not reported) (interchange of vaccine products).
Information has been received from a medical assistant concerning a 26 year old female patient with sulfonamide allergy and no pertinent medical history who on 18-MAY-2009 and 20-JUL-2009 was vaccinated IM with the first 0.5ml (lot# 1702X) and second 0.5ml (lot # unknown) doses of GARDASIL. There was no concomitant medication. On 21-JUL-2009 the patient developed a "rash all over her body" after administration of her second dose. The patient contacted the physician by phone. There were no laboratory diagnostic studies performed. On 25-JUL-2009, the patient recovered. Follow-up information has been received from a medical assistant concerning a 27 year old female patient who on 18-MAY-2009 was vaccinated with the first dose of GARDASIL (lot# 1702X). On 20-JUL-2009, the patient was vaccinated with the second dose of GARDASIL IM into the deltoid. In July 2009 (also reported as 21-JUL-2009 previously), the patient developed a rash. At the time of the report, the patient recovered. Additional information is not expected.
approx 3yrs p/vax pt devel a severe case of chickenpox. addl info req
Vaccines listed below given at approx 3:15 pm, pt then walked to lab waiting area and sat down. At approx 3:20 mother of pt started screaming. Nurses found pt slumped over in chair, unresponsive. Pt carried to exam table/room by MD - pt unresponsive for less than 1 minute. BP's stable. Pt recovered after 15 mins had some nausea, HA, dizziness. Pt reported she has passed out before with blood work, but never shots.
disequilibrium w/ambulation; ataxia; ataxia improved overnoc; sl lean to lt remained adm to hosp for tests & observation on bedrest;
Unaware of any adverse events between administration and death. Reporting agency became aware of patient's expiration on 05/14/2021.
LOSS OF MOTOR CONTROL IN LOWER EXTREMETIES STARTING APPROX 11/11/11. DEVELOPED BOWEL AND BLADDER INCONTINENCE.
This spontaneous report as received from a licensed vocational nurse refers to patients of unknown age and gender. The patients' concurrent condition, medical history or concomitant medications were not reported. The nurse reported that on unspecified dates in August 2015, since 05-AUG-2015, the patients were vaccinated with improperly stored (Merck) VARIVAX (dose and route of administration unspecified). The following vaccines were improperly stored, however the nurse did not specify which exact lost were administered: lot # L010146 expiry date 24-MAR-2017, lot # K021486 expiry date 03-NOV-2016, lot # K010338 expiry date 22-JUL-2016, lot # K026386 expiry date 15-DEC-2016, lot # L013827 expiry date 21-APR-2017. No adverse experiences were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Every since I got the vaccine my cycles has been irregular periods. It is coming every two weeks and I cramps more now then before. I hurts in my back like muscles spams. I saw a difference with the dose 2 vaccine. But it got better and now it has started all over again. I had to get on birth control to try and control it but it isn't working. I have to wait 3 months to get it switch to another birth control and that will be in June 2022.  So I have to deal with all the bleeding and pain until then.
Pt recvd 3 doses of Engerix-B 19SEP90, 19OCT90 & 3rd dose given 18MAR91 & it was determined that pt was a non-responder; No tx given;
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2022 at 5:00 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 28-Jan-2022 at 5:00 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   It was unknown if any prescriptions, over-the-counter-medications, dietary supplements, or herbal remedies were being taken by the patient at the time of vaccination and/or at the time of the adverse event.  No treatment information was provided
This case was reported by a healthcare professional and described the occurrence of hive in a 59-year-old female subject who was vaccinated with influenza virus vaccine (manufacturer unspecified) for prophylaxis. The subject's medical history included allergies and asthma. On an unspecified date before 22 August 2006, the subject received a dose of Influenza virus vaccine (lot number not provided). At an unspecified date on or before 22 August 2006, the subject experienced hive and swelling. The subject was seen at physician's office. At the time of initial reporting, 07 September 2006, the outcome of the events was not reported. Report received via manufacturer.
I incorrectly administer Kinrix to my pt who was 1 year and 6 months old.  I grabbed the Kinrix instead of the Infanrix.
Pain in body; Headache; Chills; Fever of 100; This is a spontaneous report from a non-contactable consumer. A 42-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 24Jul2021 at 10:00 in the left arm (at the age of 42-year-old) as single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Jul2021 at 10:00, the patient had headache, chills, fever of 100 and pain in her body. Therapeutic measures were taken as a result of the events and included treatment with TYLENOL every 4 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, chills, fever of 100 and pain in body was not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient had diarrhea that started about half a day after the vaccine was received (7/22/21). He presented to the emergency department 7/24/21 with chief complaint of diarrhea and bilateral lower extremity weakness.
mom states pt had sz activity 6AUG94, for 1-2 mins w/limpness & jerking/twisting of rt arm, lost conciousness, limpness;
14 hours after vaccine- flu like symptoms started.  Body aches,  strong head ache,  fatigue,  chills, fever, loss of appetite.  Also very painful at injection site.  Symptoms continued until 42 hours after vaccine. At 42 hours post vaccine, fever and body aches and head ache eased.  Decreased appetite continued.  At 47 hours post vaccine diarrhea started and lasted for 2-3 hours.
Shortness of breath, chest pressure, stomach problem, nausea, tiredness. Weight loss, Anxiety attacks
Slightly darker in color/ Large dark hyperpigmented patch; Mild burning and stinging; Not able to wear clothing covering that area of skin as it was too sensitive; Mild burning and stinging/ intense burning and stinging; Large red mark 1-2 inches from injection side; Large red mark; Rash appeared overnight; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 03Mar2021 15:45 (at the age of 39-year-old) (Lot Number: EJ1685) as dose 1, single for COVID-19 immunization. Medical history included skin sensitivities to detergents. The patient was not pregnant at the time of vaccination. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), levonorgestrel (LEVONORGESTREL) both taken for an unspecified indication, start and stop dates were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. On 04Mar2021 06:30, the patient experienced large dark hyperpigmented patch/rash appeared overnight, large red mark 1-2 inches from injection side, does not burn or itch, and reported that when arm was iced, the mark (skin in that area) felt more rough. The patient reported that it looked similar to COVID arm pictures found on google. On 05Mar2021 07:00, reaction are almost completely disappeared. On 06Mar2021 11:00 (day 3, post vaccine), reaction are reappeared with shape slightly changed. The patient had intense burning and stinging, for which she applied ointment which provided relief. She was not able to wear clothing covering that area of skin as it was too sensitive. On 07Mar2021, 09:45, reaction area and shape was about the same as the day before, and was slightly darker in color. (Morning & Daytime) Mild burning and stinging, applied ointment which provided relief, was able to wear a shirt over the area. (Evening) Burning and stinging amplified around 20:00, ointment did not provide relief, took 800 mg of ibuprofen to dull the pain, not able to wear clothing over the area. The outcome of the events was not recovered. The event large dark hyperpigmented patch/rash appeared overnight, large red mark 1-2 inches from injection side, does not burn or itch was assessed as non-serious.  No follow-up attempts are needed. No further information is expected.
Patient reported on 10/12/21 complaining of bruising/hematoma/soreness at location of Fluzone HD vaccine.  He said the symptoms were first noticed on 10/10/21.  The patient has used warm compresses.  The bruise is approximately 1.5 inches in diameter.
pt states that about 14 days after taking the covid vax that she noticed a lump on her left arm around the injection site.  Today 3/5/2021 she had developed a a 3 x 5 itchy red rash on left arm where the lump was at the day before.  Pt has not put any medicine on it or contacted her PCP at this time.
pt devel lightheadedness & fatigue following vax w/MMR; pt recovered;
This spontaneous report as received from a nurse refers to a female patient of age in her 50's. There was medical history and no known drug reactions or allergies was reported. The patient was vaccinated with a dose of 1 ml of RECOMBIVAX HB (lot number reported as 1106AA and expiry date unspecified) given intramuscularly with first dose on 28-OCT-2011, second dose on 29-NOV-2011 and the third dose on 27-APR-2012. No other co-suspects were reported. No concomitant medications were reported. On an unknown date in 2012, the patient experienced negative hepatitis B surface antibody titers. No treatment was given. The patient sought medical attention and visited the physician's office. The outcome of negative hepatitis B surface antibody titers was not recovered at the time of report. The relatedness for the event was unknown for RECOMBIVAX HB. The patient was in the process of repeating the 3 dose series of RECOMBIVAX HB. The case was linked to case # 1210USA006250 and # 1210USA006251 (due to the same reporter link). Additional information is not expected.
Presents for SOB & abnormal labs from nursing home. Admit for acute respiratory failure with hypoxia secondary to COVID pneumonia. Tx: steroids, abx, bipap. Respiratory status continued to worsen thus palliative care consult was made & decision to transition to inpatient hospice for comfort care. DC to inpatient hospice; pt expired x2 days later.
A report has been received from a Physician concerning an 8 month old, male subject, who had been receiving nasal FLUMIST Quadrivalent. FLUMIST Quadrivalent started on 25-NOV-2014. Vaccine was administered to a patient under 2  years old thus wrongful administration which started on 25-NOV-2014. The outcome of the event of wrongful administration is unknown. The report was considered to be non-serious. The reporter considered that there was no casual relationship between wrongful administration and FLUMIST Quadrivalent. The company physician considered that there was no casual relationship between wrongful administration and FLUMIST Quadrivalent.
Pfizer vial was stored frozen past the manufacturers storage recommendation of 2 weeks.  Patient will be notified and offered a repeat dose
Breakout in a rash on arms, face, back, mild case. Does not appear to be sick. Approximately 15-20 lesions, very small, seen by MD on 9/29/03.
Threw up shortly after second dose Extremely tired Unable to eat for days Lightheaded Lesions on vulva Pain, unable to walk Pain, unable to use bathroom Unable to leave bed
pt vaxed 12NOV92 & then onset progressive generalized weakness 17NOV92 worsening until 7DEC92 when hospitalized due to inability to care for self; currently receiving plasma exchange treatment-GBS;
Soreness at site for 2 days; Itchiness began 26 hours after vaccine. No rash.
This spontaneous report has been received from a nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of M-M-R II lot # M045392, expiration date 14-NOV-2018 and lot # M045401, expiration date 14-NOV-2018 (dose and route of administration were not reported). The vaccines were reconstituted with properly stored sterile diluent (MERCK). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 10.9 degrees Celsius for 3 hours and 17 minutes. Digital data logger was involved. There were no previous excursions reported. No product quality complaint has been filled. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA007137: US-009507513-1709USA007139: US-009507513-1709USA004848.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 04-DEC-2015, the patient was vaccinated with improperly stored dose of VARIVAX (Merck) lot # L021214, expiry date 10-JUN-2017 (strength, dose, route of administration and anatomical location were not reported). No adverse effects were reported. Product quality complaint (PQC) was not reported. This is one of several reports received from the same source. Additional information has been requested.
One day after the injection I had a large red patch that turned mildly itchy around day 2.  I also had mild chills and a low-grade fever that lasted 24 hours. The rash on my arm went away on day 5, however, I could still feel a bump where it had been.   On day 8 The red round rash reappeared. I've read it's called covid arm. It's been 48 hours and it's still there.  It's bigger than the original patch and doesn't have its round form, more spread out. It itches and is darker where the actual injection took place.
pt recv vax 9SEP97 & devel a local cellulitis @ the inj site;tx w/med;pt recovered;
Myalgia, Fever, Sweating, Chills Narrative:  Received 2nd dose on 1/26/21 and noted onset of myalgias that evening. On 1/27/21 noted fever, myalgias, sweating and chills. Symptoms resolved by 1/28/21. Missed work x 1 day. No known prior COVID infection.
The morning after my injection, I woke up with swollen lymph nodes in my neck (on the left side) and at the base of my skull (in the back on the left side). I also had swollen tonsils. Additionally, the muscles in my shoulder, neck and head (on the left side- where I was given the injection) were tense and painful. It hurt to move them despite stretching them, massaging my shoulder and neck, applying ice to the areas to lower the swelling (for several hours), and ibuprophen. I am also fatigued, but I am told that this is a "normal" reaction to the vaccine. It is the second day and the swelling in my lymph nodes is less than yesterday, although they are still swollen, and the pain in my neck and shoulder is not as painful, but I still cannot turn my head quickly, and it is so stiff in the back of my neck that it hurts to lean my head back. I can lean my head back, but I have to take it very slowly, otherwise there is shooting pain.
Patient received PNEUMOVAX 23 to right deltoid on 5/24/17. Reported pain, redness, swelling in same area on 5/25/17. Seen in office, site red and hot to touch. Treatment OTC BENADRYL and ibuprofen.
Information has been received from a physician concerning an 11 year old female who on 27-SEP-2007 was vaccinated with a second 0.5mL dose of varicella virus vaccine live (Oka/Merck), (lot number not reported). On 27-SEP-2007, the patient developed a chicken pox rash that started on the patient's scalp and then moved to her face, chest, arms and legs. The patient also developed a fever of 101 degrees F. No further information was available. The outcome was reported as recovered. Unspecified medical attention was sought. There was no product quality complaint. Follow up information has been received from a physician concerning an 11 year old female with no pre-existing allergies, or medical conditions who on 23-MAR-1998 was vaccinated subcutaneously into the right arm with a second dose of varicella virus vaccine live (Oka/Merck) (658293/1102U). Concomitant vaccine therapy administered within four weeks of varicella virus live included a first dose of Gardasil administered intramuscularly (IM) (Lot #656372/0243U), a sixth dose of Tripedia (Lot # C2770AA) administered IM into the left arm and a first dose of Menactra (Lot # N2339AA), administered IM. On 27-SEP-2007, at 10:00, the patient developed a rash on her scalp, and moved to her face, chest, arms and legs. The patient complained of severe itching. the patient was seen at the doctor's office for a history of a fever up to 101 F. Observations at that time included a vesicular papular rash all over her face, arms, legs, chest and abdomen. The patient was advised to remain off from school at home, and isolated from siblings. No follow up was required unless problems should arise. No diagnostics labs studies obtained. There was no concomitant therapy. Medical attention was sought. There was not illness at the time of vaccination. There were no adverse events following previous vaccinations. At the time of reporting the patient's status was unknown (previously reported as recovered). Additional information is not expected.
A blister appeared on the tip of the small finger on the right hand about 40 hours after the injection.  The blister continues to expand, leaving discolored skin.  The outer edge is white and the inner area is light brown.  Skin is like a callous.  It is not painful, but continues to expand up the finger.
Red round lesion "larger than a silver dollar" per mom; pain and warmth at site; pt to crease of elbow.  No numbness or tingling.
approx 24-28 p/vax lt upper arm, became very painful, reddened, hot to touch, developing to 10 x 20 cm area of induration;also h/a, chills, fever, body aches x 2 days;
Information has been reported in a study. The report concerns death reports in adult ages 19 years and Older following PNEUMOVAX 23. The report includes VAERS reports following PNEUMOVAX 23 or Pneumococcal polysaccharide vaccine (PPSV23) brand unknown after 2002. The report includes reports information from 01-JAN-1990 to 13-JAN-2014. This spontaneous report as received from an other health professional refers to 1 patient. The median age of the patients was 69 years old; range being 23 to 98 years. Between 01-JAN-1990 and 31-DEC-2013 patients were vaccinated with PNEUMOVAX 23. On an unknown date the patients experienced death. The cause of death was reported as gastrointestinal. The death of the patients was confirmed with medical records, autopsy reports and/or death certificates. The report concerns death reports in adult ages 19 and Older following PNEUMOVAX 23. The report has been split into cases according to cause of death. This case is linked to same reporter linked cases # 1406USA003857 (respiratory disorder), # 1406USA003863 (Unknown), # 1406USA003859 (other non infectious disorder), # 1406USA003858 (other infectious), # 1406USA003861 (Neurological), # 1406USA003862 (Undetermined) and # 1406USA003351 (Cardiovascular). Additional information has been requested.
Erythema, swelling, tenderness, pruritus x 3 days.  tx: BENADRYL/MOTRIN.